KDR and breast cancer: The aim of this study was to characterize the patterns of pathologic angiogenesis in various therapeutically relevant molecular breast cancer subtypes (HR+, HER2+, TNBC) by evaluation of vascular density and immunohistochemical expression of VEGFR2 protein in a retrospective series of primary human breast cancer tissues.